Robert Thomas Freeman Sells 218,295 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CFO Robert Thomas Freeman sold 218,295 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $15.53, for a total value of $3,390,121.35. Following the completion of the sale, the chief financial officer now owns 1,417,554 shares of the company's stock, valued at $22,014,613.62. The trade was a 13.34 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.58, for a total transaction of $3,895,000.00.

Alignment Healthcare Trading Up 0.9 %

Shares of NASDAQ ALHC traded up $0.13 during trading on Monday, reaching $15.02. The stock had a trading volume of 2,232,665 shares, compared to its average volume of 2,080,941. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The company has a market cap of $2.88 billion, a P/E ratio of -19.51 and a beta of 1.49. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $16.25. The business's 50-day moving average price is $13.97 and its 200-day moving average price is $12.23.

Remove Ads

Analyst Ratings Changes

Several analysts have commented on the company. Bank of America increased their target price on Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a research note on Tuesday, March 4th. Stephens reiterated an "overweight" rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Monday, February 24th. Stifel Nicolaus increased their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. increased their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a report on Thursday. Finally, Piper Sandler upped their price objective on Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Alignment Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $14.83.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in ALHC. Vanguard Group Inc. boosted its position in shares of Alignment Healthcare by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company's stock worth $110,453,000 after acquiring an additional 166,837 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Alignment Healthcare by 54.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock valued at $97,302,000 after buying an additional 3,059,596 shares in the last quarter. Wellington Management Group LLP grew its position in shares of Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock valued at $83,683,000 after buying an additional 3,257,630 shares during the last quarter. Hood River Capital Management LLC lifted its holdings in shares of Alignment Healthcare by 39.6% in the 4th quarter. Hood River Capital Management LLC now owns 4,952,995 shares of the company's stock valued at $55,721,000 after purchasing an additional 1,405,212 shares during the last quarter. Finally, 8 Knots Management LLC grew its stake in Alignment Healthcare by 49.5% during the 4th quarter. 8 Knots Management LLC now owns 3,658,695 shares of the company's stock worth $41,160,000 after buying an additional 1,211,727 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.